Xanthine oxidase — Drug Target

All drugs that target Xanthine oxidase — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Xanthine oxidase inhibitor · xanthine oxidase inhibitor

Marketed (3)

• allopurinol sustained-release capsules · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Xanthine oxidase inhibitor · Rheumatology / Metabolic disorders
  Allopurinol inhibits xanthine oxidase, the enzyme responsible for converting hypoxanthine and xanthine to uric acid, thereby reducing serum and urinary uric acid levels.
• AL · Medecins Sans Frontieres, Netherlands · xanthine oxidase inhibitor · Rheumatology
  Allopurinol works by inhibiting the enzyme xanthine oxidase, which is involved in the production of uric acid.
• Allopurinol Tablet · Haiphong University of Medicine and Pharmacy · Xanthine oxidase inhibitor · Rheumatology / Metabolic disorders
  Allopurinol inhibits xanthine oxidase, an enzyme that converts hypoxanthine and xanthine to uric acid, thereby reducing serum and urinary uric acid levels.

Phase 3 pipeline (1)

• Febuxostat IR · Takeda · Xanthine oxidase inhibitor · Rheumatology
  Febuxostat is a selective xanthine oxidase inhibitor that reduces uric acid production by blocking the enzyme responsible for converting hypoxanthine and xanthine to uric acid.